Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients (Q34344146)
scientific article published on September 28, 2010
Language:
(P31) (Q13442814)
(P50) (Q107718318)
(Q89094899)
(P304) 1331-1334
(P407) (Q1860)
(P433) 9
(P478) 103
(P577) Tuesday, September 28, 2010
(P921) (Q12859063)
(Q412616)
(P953) https://www.nature.com/articles/6605918.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20877352/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20877352/pdf/?tool=EBI
https://europepmc.org/articles/PMC2990606
https://europepmc.org/articles/PMC2990606?pdf=render
http://www.nature.com/articles/6605918.pdf
http://www.nature.com/articles/6605918
(P1433) (Q326309)
(P1476) "Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients" (language: en)
(P2093) Y. C. Cheng
V. Valero
M. L. Davis
M. C. Green
R. L. Theriault
J. L. Murray
G. N. Hortobagyi
(P2860) (Q40144433)
(Q27824835)
(Q40571024)
(Q35644613)
(Q34288123)
(Q35211298)
(Q38521735)
(Q40725921)
(Q34417576)
(Q27824766)
(Q40782438)
(Q40630247)
(Q33730975)
(Q40939932)
(Q28375856)
(Q28277632)
(Q47854934)
(Q40927247)
(Q41433309)
(Q33497695)
(Q38485006)
(Q54170195)
(Q40442632)
(Q27860693)
(Q43892783)
(Q34500435)
(Q46940456)
(Q41690264)
(Q41645362)
(Q43937165)
(Q53985281)
(Q44951992)
(Q46616504)
(Q53620808)
(Q47766707)
(Q43607758)
(Q70398906)
(Q70282328)
(Q69351848)
(Q68412504)
(Q67832624)
(Q72228246)
(Q72234622)
(Q74195368)
other details
description scientific article published on September 28, 2010

External Links